Palforzia® is designed to gradually increase the body’s ability to tolerate small amounts of peanut (desensitisation) through carefully controlled and supervised initial dose escalation, up-dosing and ...
This robust expansion, driven by a CAGR of 6.58% during the forecast period (2024–2032), highlights the rising demand for advanced treatment solutions for chronic ocular pain ... over seven hours ...